Isolation and Characterization of Bacteriophages Targeting MRSA ID: 2014-075
An innovative approach to combating methicillin-resistant Staphylococcus aureus (MRSA) infections through the discovery of 19 novel bacteriophages.
Photo by starlineart - stock.adobe.com
Technology Overview
This technology involves the isolation and detailed characterization of 19 new bacteriophages capable of lysing MRSA strains, offering a potential breakthrough in treating bacterial infections resistant to conventional antibiotics. Developed at Brigham Young University, this invention not only presents a novel method to address antibiotic resistance but also provides a viable option for disinfecting environments contaminated with MRSA, such as hospitals and veterinary clinics.
Key Advantages
- Targets methicillin-resistant Staphylococcus aureus (MRSA), a major cause of hospital-acquired infections
- Offers a potential alternative to antibiotics, addressing the growing issue of antibiotic resistance
- Applicable in both medical and veterinary settings, enhancing versatility
- Provides options for disinfecting contaminated surfaces, contributing to infection control efforts
Problems Addressed
- Combatting antibiotic-resistant bacterial infections
- Reducing the spread of MRSA in healthcare and veterinary environments
- Offering new therapeutic options for infections with limited treatment availability
Market Applications
- Pharmaceutical development for new antibacterial treatments
- Disinfectant products for hospital, veterinary, and public use
- Research tools for studying bacteriophage therapy and antibiotic resistance
Additional Information
Technology ID: 2014-075
Sell Sheet: Download the Sell Sheet here
Market Analysis: Contact us for a more in-depth market report
Date Published: 07 May, 2025
Connect with the Tech Transfer to:
- Meet with the technology manager
- Receive additional information
- Request a marketing plan report